Nucleofill Treatment in London

Nucleofill is administered via fine needle injection into the dermis of the planned treatment area. Sessions generally take between 30 and 45 minutes. The formulation used — and the concentration selected — depends on individual skin condition, the area being treated, and the goals established during your initial consultation. Most patients complete a course of two to three sessions, spaced several weeks apart, to allow gradual polynucleotide activity to develop.

As with any injectable treatment, nucleofill carries potential risks and considerations that must be evaluated before proceeding. Commonly reported effects include temporary redness, swelling, tenderness, or bruising at injection sites, which typically resolve within a few days. Rarer considerations include infection or localised reaction. Every treatment carries potential risks, and individual suitability is assessed carefully through a face-to-face consultation prior to any procedure being carried out.

The appropriate session count depends on skin condition, the severity of concerns, and the goals established during consultation. Many patients begin with a course of two to three sessions spaced several weeks apart to allow cumulative effects to develop. Single sessions may suit patients with milder concerns or those already in a maintenance phase. A personalised treatment plan confirming session frequency is confirmed following your clinical assessment.

The longevity of improvement varies according to individual factors, including age, skin condition, lifestyle, and the number of sessions completed. Patients who complete a full course often describe improvements in hydration, texture, and skin quality persisting for several months following treatment. Maintenance sessions are commonly recommended to sustain results over time. A clinical assessment during your consultation helps establish realistic expectations based on your specific concerns and agreed plan.

Most patients describe nucleofill as tolerable, with mild stinging or discomfort at injection sites during the procedure. Where treatment is planned for more sensitive areas, including around the eyes, a topical anaesthetic may be applied in advance. Discomfort typically resolves promptly once the session is complete. Your practitioner will adjust the approach where necessary to support comfort throughout and can discuss what to expect before treatment begins.

Nucleofill is generally associated with minimal downtime. Some patients experience mild redness, localised swelling, or slight sensitivity in the treatment area for 24 to 48 hours following the session. These responses are typically transient and consistent with normal tissue activity during the early period after injection. Detailed aftercare guidance is provided at the end of each treatment. Most individuals are able to resume their usual daily activities shortly following their appointment.

Nucleofill may be appropriate for adults experiencing fine lines and wrinkles, loss of hydration, early signs of ageing, uneven skin texture, or reduced firmness. Scalp applications may also be considered for individuals with reduced follicle activity. Suitability depends on overall health, skin condition, and medical history. Individuals who are pregnant, breastfeeding, or who present with certain underlying health conditions may not be suitable candidates at this time.

Nucleofill is a polynucleotide-based biostimulator — it contains no hyaluronic acid and does not add volume in the way that dermal fillers do. Its action is cellular rather than structural, aiming to improve skin quality through regenerative signalling. Profhilo is a hyaluronic acid skin booster that improves hydration and tissue remodelling via a different mechanism. The most appropriate option depends on the patient’s specific concerns and is determined through clinical assessment.